Challenges introduced by Japan's drug pricing policy

被引:0
|
作者
Kinoshita, Shotaro [1 ,2 ]
Kishimoto, Taishiro [1 ]
机构
[1] Keio Univ, Sch Med, Hills Joint Res Lab Future Prevent Med & Wellness, 7F Azabudai Hills Mori JP Tower 1-3-1 Azabudai,Min, Tokyo 1060041, Japan
[2] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, 7-3-1 Hongo,Bunkyo ku, Tokyo 1130033, Japan
来源
关键词
D O I
10.1016/j.lanwpc.2024.101212
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Challenges for language policy in today's Japan
    Gottlieb, Nanette
    [J]. LANGUAGE REGIMES IN TRANSFORMATION, 2007, 93 : 33 - 70
  • [2] China's Japan Policy: Adjusting to New Challenges
    King, Amy
    [J]. CHINA JOURNAL, 2016, 75 : 148 - 150
  • [3] CHINA'S JAPAN POLICY: Adjusting to New Challenges
    Sun, Jing
    [J]. PACIFIC AFFAIRS, 2016, 89 (02) : 413 - 415
  • [4] The government's drug pricing policy is falling apart messily
    Hawkes, Nigel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [5] THE IMPACT OF GENERIC DRUG POLICY ON DRUG PRICING
    Lee, B.
    Garay, O. U.
    Goldhaber-Fiebert, J.
    Wilson, L. S.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [6] Japan's Post-Fukushima Energy Policy Challenges
    Koyama, Ken
    [J]. ASIAN ECONOMIC POLICY REVIEW, 2013, 8 (02) : 274 - 293
  • [7] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shibata, Shoyo
    Fukumoto, Daigo
    Suzuki, Takeshi
    Ozaki, Koken
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (03) : 544 - 551
  • [8] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shoyo Shibata
    Daigo Fukumoto
    Takeshi Suzuki
    Koken Ozaki
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 544 - 551
  • [9] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shibata, Shoyo
    Fukumoto, Daigo
    Suzuki, Takeshi
    Ozaki, Koken
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019,
  • [10] PRICING POLICY FOR PHARMACEUTICALS IN EGYPT: CHALLENGES AND OPPORTUNITIES
    Ragab, S.
    Dias, M.
    Hassan, R.
    Abou Shady
    El-Sisi, G.
    Kalo, Z.
    Abazs, S.
    Shaheen, M.
    Abbas, Y.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A523 - A523